title: Safety, reactogenicity and immunogenicity of Madin Darby Canine Kidney cell-derived inactivated influenza subunit vaccine. A meta-analysis of clinical studies.
authors.affiliation: Solvay Pharmaceuticals B.V., Weesp, The Netherlands.
authors.forename: A M
authors.initials: AM
authors.lastname: Palache
authors.forename: H S
authors.initials: HS
authors.lastname: Scheepers
authors.forename: V
authors.initials: V
authors.lastname: de Regt
authors.forename: P
authors.initials: P
authors.lastname: van Ewijk
authors.forename: M
authors.initials: M
authors.lastname: Baljet
authors.forename: R
authors.initials: R
authors.lastname: Brands
authors.forename: G J
authors.initials: GJ
authors.lastname: van Scharrenburg
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D002460:Cell Line; D002642:Chick Embryo; D003257:Consumer Product Safety; D004285:Dogs; D005260:Female; D006801:Humans; D006967:Hypersensitivity; D009980:Influenza A virus / Q000276:immunology*; D009981:Influenza B virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000009:adverse effects / Q000276:immunology*; D007700:Kinetics; D008297:Male; D014422:Turkeys; D014611:Vaccination; D015164:Vaccines, Inactivated / Q000009:adverse effects / Q000276:immunology; D014776:Virus Cultivation
chemical_list: D000914:Antibodies, Viral; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated